IB Net Payout Yields Model

Invest like me - only at Covestor.com

Missing the Bottom on Anadigics

By -


Having watched the market fall apart the last 16 months, it's no surprise that a small cap tech stock like Anadigics (ANAD) has been hit hard. The amount of the fall might be surprising though considering they have an impressive balance sheet. So many professionals scream on CNBC all day that they want to invest in companies that don't need cash yet stocks like ANAD and another favorite of Stone Fox Capital, Alvarion (ALVR), have fallen to levels that equal cash. Basically the remaining company was valued as worthless.

As survivors of the tech bust in 2000, you'd think investors would give these companies a greater benefit of the doubt. Much more willing to look beyond the current climate and realize that they will be survivors. Times may be bad, but with their balance sheet they'll clearly survive and maybe thrive when we come out of this as the competition might be greatly reduced with the weak competitors not surviving. Recessions aren't always bad if a company can garner market share.




  • ANAD had roughly $2.5 in cash after the Q3 report. This has likely declined and the results could've been worse then expected considering the environment in Q4.


  • As of September 27, 2008 cash and short and long-term marketable securities totaled $152.2 million compared with $161.4 million at June 28, 2008.

  • Net sales for the fourth quarter 2008 are estimated to be in the range of $44 million to $46 million. Net sales at this level would represent an approximate 32% to 35% decrease on a comparable basis with fourth quarter 2007. Net loss per share on a GAAP basis for the fourth quarter 2008 is expected to approximate $0.19 to $0.21. Pro forma loss per share, excluding non-cash stock compensation expense, is expected to be in the range of approximately $0.12 - $0.14. The net loss and pro forma loss per share are based on an estimated diluted weighted average outstanding common share count of 61 million.


Though the numbers seem bad the stock got down into the $1s making this stock trade for an Enterprise Value in the $0 range. Unfortunately we missed that bottom, but it currently looks very tasty at $2.38. From a technical standpoint the stock is bouncing along above the 20 day ema and a nice rising 50 day ema. The earnings report on the 26th will be volatile so be careful, but the valuation and technicals on ANAD are very appealing.

Comments

Mark Holder said…
ANAD quickly drops to the 50day ema in this weak market. Potentially a good place to add with a tight stop.
February 19, 2009 at 11:33 AM
Post a Comment

Popular posts from this blog

Aurora Cannabis: Deal Or No Deal

By -
Aurora Cannabis was left out of the major deal making in 2018. The cannabis company updated FQ2 guidance to revenues of $50 to $55 million with a continued focus on pure production growth. The stock is down as the market is becoming less impressed with commodity farming operations due to the prime Oregon example. The stock is below key resistance at $5.40 as medical cannabis patient totals failed to impress. As the end of 2018 came and went,   Aurora Cannabis   ( ACB ) was a notable absentee from the deal making in the cannabis market. Just about all of the other major Canadian cannabis players got large investments or signed up powerful partnerships, but the related stocks didn't generally maintain rallies following the deals. Based on the early legalization data in Canada and Oregon, the best option for Aurora Cannabis might actually be selling production capacity while the Canadian market remains hot. Read the full article on Seeking Alpha.  Disclosure: No
Read more

C3.ai: Out Of Steam (Rating Downgrade)

By -
Image
This idea was discussed in more depth with members of my private investing community, Out Fox The Street.  Learn More »   Update - June 23, 2023 C3.ai has fallen back to earth after the Investor Day meeting. The Deutsche Bank analyst call on the meeting suggests the company still isn't ready to produce actual numbers from the generative AI demand.  C3.ai ( NYSE: AI ) shares  fell more than 8%  on Friday after investment firm Deutsche Bank reiterated its sell rating on the enterprise software company after it held its investor meeting. Analyst Brad Zelnick said the event "left a lot to be desired" as there were  no details on financials, "limited" updates on the company's operations and investors did not really attend the event, despite it being positioned as for them. "While we appreciate the vast opportunity presented by AI, the event did nothing to ease our skepticism on the true differentiation of the company's platform, its traction with custome
Read more

Archer Aviation: Promising Developments

By -
Image
  Update - June 12, 2023 Archer is finally in the midst of a breakout on the positive FAA news.  -The acting administrator of the Federal Aviation Administration, Billy Nolen, is in talks to join Archer Aviation (NYSE:ACHR), per a report from Reuters. -Citing sources familiar with the situation, the report indicates Nolen will depart his current position atop the FAA in the next few weeks and will then look to transition to a role at Archer (ACHR). Archer’s rival Joby Aviation (JOBY) previously appointed former FAA chief Michael Huerta to a position on its board in March. Original article posted on Jan. 19 This idea was discussed in more depth with members of my private investing community, Out Fox The Street.  Learn More »   Archer Aviation Inc. jumped to $3 on the excitement of small insider purchases. The eVTOL manufacturer recently announced several major developments towards FAA certification and production of the Midnight aircraft. Archer Aviation stock is interesting, with a $70
Read more